181 related articles for article (PubMed ID: 26281770)
1. Treatment with the combination of ibandronate plus eldecalcitol has a synergistic effect on inhibition of bone resorption without suppressing bone formation in ovariectomized rats.
Sakai S; Takeda S; Sugimoto M; Shimizu M; Shimonaka Y; Yogo K; Hashimoto J; Bauss F; Endo K
Bone; 2015 Dec; 81():449-458. PubMed ID: 26281770
[TBL] [Abstract][Full Text] [Related]
2. Effects of treatment with ibandronate on bone mass, architecture, biomechanical properties, and bone concentration of ibandronate in ovariectomized aged rats.
Bauss F; Lalla S; Endele R; Hothorn LA
J Rheumatol; 2002 Oct; 29(10):2200-8. PubMed ID: 12375334
[TBL] [Abstract][Full Text] [Related]
3. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
[TBL] [Abstract][Full Text] [Related]
4. Eldecalcitol Induces Minimodeling-Based Bone Formation and Inhibits Sclerostin Synthesis Preferentially in the Epiphyses Rather than the Metaphyses of the Long Bones in Rats.
Hasegawa T; Yamamoto T; Hongo H; Yamamoto T; Haraguchi-Kitakamae M; Ishizu H; Shimizu T; Saito H; Sakai S; Yogo K; Matsumoto Y; Amizuka N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673844
[TBL] [Abstract][Full Text] [Related]
5. The therapeutic effect to eldecalcitol + bisphosphonate is superior to bisphosphonate alone in the treatment of osteoporosis: a meta-analysis.
Zheng Z; Luo J
J Orthop Surg Res; 2020 Sep; 15(1):390. PubMed ID: 32907639
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate tiludronate increases bone strength by improving mass and structure in established osteopenia after ovariectomy in rats.
Ohnishi H; Nakamura T; Narusawa K; Murakami H; Abe M; Barbier A; Suzuki K
Bone; 1997 Oct; 21(4):335-43. PubMed ID: 9315337
[TBL] [Abstract][Full Text] [Related]
7. Intermittent intravenous administration of the bisphosphonate ibandronate prevents bone loss and maintains bone strength and quality in ovariectomized cynomolgus monkeys.
Smith SY; Recker RR; Hannan M; Müller R; Bauss F
Bone; 2003 Jan; 32(1):45-55. PubMed ID: 12584035
[TBL] [Abstract][Full Text] [Related]
8. Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid.
Glatt M; Pataki A; Evans GP; Hornby SB; Green JR
Osteoporos Int; 2004 Sep; 15(9):707-15. PubMed ID: 15024556
[TBL] [Abstract][Full Text] [Related]
9. New bone formation with teriparatide [human parathyroid hormone-(1-34)] is not retarded by long-term pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
Ma YL; Bryant HU; Zeng Q; Schmidt A; Hoover J; Cole HW; Yao W; Jee WS; Sato M
Endocrinology; 2003 May; 144(5):2008-15. PubMed ID: 12697709
[TBL] [Abstract][Full Text] [Related]
10. Effects of D-003, a mixture of high molecular weight aliphatic acids from sugar cane wax, on bones from ovariectomized rats.
Noa M; Más R; Mendoza S; Gámez R; Mendoza N
Drugs Exp Clin Res; 2004; 30(1):35-41. PubMed ID: 15134389
[TBL] [Abstract][Full Text] [Related]
11. Effect of minocycline on osteoporosis.
Williams S; Wakisaka A; Zeng QQ; Barnes J; Seyedin S; Martin G; Wechter WJ; Liang CT
Adv Dent Res; 1998 Nov; 12(2):71-5. PubMed ID: 9972125
[TBL] [Abstract][Full Text] [Related]
12. Uncoupling between bone formation and resorption in ovariectomized rats with chronic cadmium exposure.
Uriu K; Morimoto I; Kai K; Okazaki Y; Okada Y; Qie YL; Okimoto N; Kaizu K; Nakamura T; Eto S
Toxicol Appl Pharmacol; 2000 May; 164(3):264-72. PubMed ID: 10799336
[TBL] [Abstract][Full Text] [Related]
13. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
Weber K; Goldberg M; Stangassinger M; Erben RG
J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
[TBL] [Abstract][Full Text] [Related]
14. 1alpha-hydroxyvitamin D2 partially dissociates between preservation of cancellous bone mass and effects on calcium homeostasis in ovariectomized rats.
Erben RG; Bante U; Birner H; Stangassinger M
Calcif Tissue Int; 1997 May; 60(5):449-56. PubMed ID: 9115163
[TBL] [Abstract][Full Text] [Related]
15. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
16. A new synthetic steroid, osaterone acetate (TZP-4238), increases cortical bone mass and strength by enhancing bone formation in ovariectomized rats.
Fuse H; Fukumoto S; Sone H; Miyata Y; Saito T; Nakayama K; Takahashi H; Matsumoto T; Ogata E
J Bone Miner Res; 1997 Apr; 12(4):590-7. PubMed ID: 9101370
[TBL] [Abstract][Full Text] [Related]
17. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
Iwaniec UT; Mosekilde L; Mitova-Caneva NG; Thomsen JS; Wronski TJ
Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
[TBL] [Abstract][Full Text] [Related]
18. A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study.
Ramamurthy N; Bain S; Liang CT; Barnes J; Llavaneras A; Liu Y; Puerner D; Strachan MJ; Golub LM
Curr Med Chem; 2001 Feb; 8(3):295-303. PubMed ID: 11172684
[TBL] [Abstract][Full Text] [Related]
19. Influence of aging on cortical and trabecular bone response to estradiol treatment in ovariectomized rats.
Gaumet N; Braillon P; Seibel MJ; Pointillart A; Coxam V; Davicco MJ
Gerontology; 1998; 44(3):132-9. PubMed ID: 9592683
[TBL] [Abstract][Full Text] [Related]
20. Effect of monoclonal anti-human gp130 antibody (GPX7) on bone turnover in normal and ovariectomized rats.
Nishida S; Okimoto N; Okazaki Y; Yamaguchi A; Kumegawa M; Yasukawa K; Murayama K; Nakamura T
Calcif Tissue Int; 1998 Mar; 62(3):227-36. PubMed ID: 9501956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
